Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-15-012362
Filing Date
2015-11-20
Accepted
2015-11-20 16:11:06
Documents
4

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 25119
2 GRAPHIC g90929g60y40.jpg GRAPHIC 3025
3 GRAPHIC g90929g76a93.jpg GRAPHIC 3346
4 GRAPHIC g90929g76g40.jpg GRAPHIC 2323
  Complete submission text file 0000950123-15-012362.txt   38403
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

EIN.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations